1.
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
by Heerspink, Hiddo J Lambers, PharmD
The Lancet (British edition), 2009, Vol.373 (9668), p.1009-1015

2.
Acute kidney injury
by Bellomo, Rinaldo, Prof
The Lancet (British edition), 2012, Vol.380 (9843), p.756-766

3.
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
by Sattar, Naveed, Prof
The Lancet (British edition), 2010, Vol.375 (9716), p.735-742

4.
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study
by Ketteler, Markus
The Lancet (British edition), 2003-03-08, Vol.361 (9360), p.827-833

5.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll...
by Baigent, Colin, Prof
The Lancet (British edition), 2011, Vol.377 (9784), p.2181-2192

6.
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
by Jamal, Sophie A, Dr
The Lancet (British edition), 2013, Vol.382 (9900), p.1268-1277

7.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
by de Zeeuw, Dick, Prof
The Lancet (British edition), 2010, Vol.376 (9752), p.1543-1551

8.
Safety and Effectiveness of Ferumoxytol in Hemodialysis Patients at 3 Dialysis Chains in the United States Over a 12-Month Period
by Schiller, Brigitte, MD
Clinical therapeutics, 2014, Vol.36 (1), p.70-83

9.
Children's experiences of dialysis: a systematic review of qualitative studies
by Tjaden, Lidwien
Archives of disease in childhood, 2012-05, Vol.97 (5), p.395-402

10.
Hyperparathyroidism
by Fraser, William D, Prof
The Lancet (British edition), 2009, Vol.374 (9684), p.145-158

11.
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
by Boaz, M
The Lancet (British edition), 2000-10-07, Vol.356 (9237), p.1213-1218

12.
Bacterial septic arthritis in adults
by Mathews, Catherine J, MRCP
The Lancet (British edition), 2010, Vol.375 (9717), p.846-855

13.
Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study
by McAllister, Todd N, Dr
The Lancet (British edition), 2009, Vol.373 (9673), p.1440-1446

14.
Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM)
by Ronco, Claudio, Dr
The Lancet (British edition), 2014, Vol.383 (9931), p.1807-1813

15.
The Obesity Paradox and Mortality Associated With Surrogates of Body Size and Muscle Mass in Patients Receiving Hemodialysis
by Kalantar-Zadeh, Kamyar, MD, MPH, PhD
Mayo Clinic proceedings, 2010, Vol.85 (11), p.991-1001

16.
Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose
by Freeman, Rosario V
The American journal of cardiology, 2002, Vol.90 (10), p.1068-1073

17.
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
by Maisonneuve, Patrick
The Lancet (British edition), 1999, Vol.354 (9173), p.93-99

18.
Pulmonary Hypertension in Patients With End-Stage Renal Disease
by Yigla, Mordechai
Chest, 2003-05, Vol.123 (5), p.1577-1582

19.
Short-Term Blood Pressure, Noradrenergic, and Vascular Effects of Nocturnal Home Hemodialysis
by Chan, Christopher T
Hypertension (Dallas, Tex. 1979), 2003-11, Vol.42 (5), p.925-931

20.
Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial
by Agarwal, Rajiv
Hypertension (Dallas, Tex. 1979), 2009-03, Vol.53 (3), p.500-507
